# US 2010/0137289 A1 · Methods and Compositions for Ameliorating Thiazide Induced Hyperlipidemia

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0137289 A1
- Document ID: US20100137289A1
- Status: Published application
- Kind: A1
- Application number: 12/531,120
- Filed: 2008-04-17
- Published: 2010-06-03
- Earliest claimed: 2007-04-17
- Inventors: Richard J. Johnson; Sirirat Reungjui; Takahiko Nakagawa
- Web page: https://patentgrep.com/patent/US20100137289A1

## CPC

- A61K 31/549: having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
- A61K 31/519: ortho- or peri-condensed with heterocyclic rings
- A61K 31/52: Purines, e.g. adenine
- A61K 31/54: having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61P 3/06: Antihyperlipidemics
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Male Disclosed herein are compositions for ameliorating the lipid producing effects of thiazide therapy. Particularly exemplified herein are compositions containing a thiazide and allopurinol, or some other xanthine oxidase inhibitor.

## Claims

### Claim 1

A reduced-lipid producing thiazide containing composition consisting essentially of a thiazide or pharmaceutically acceptable salt thereof, allopurinol, or a pharmaceutically acceptable salt thereof, and a non-active additive.

### Claim 2 (depends on 1)

The composition of claim 1, wherein said thiazide is chlorothiazide, benzylhydro-chlorothiazide, cyclopenthiazide, ethiazide, hydrochlorothiazide, hydroflumethiazide, methyclothiazide, penfluthiazide, polythiazide, or trichloromethiazide or a combination thereof.

### Claim 3 (depends on 1)

The composition of claim 1, wherein said thiazide is hydrochlorothiazide.

### Claim 4 (depends on 1)

The composition of claim 1 formulated in solid dosage form comprising a powder, granule, tablet, pill, or capsule.

### Claim 5 (depends on 1)

The composition of claim 1 formulated in a liquid suspension or solution.

### Claim 6

A method of treating hypertension comprising administering a therapeutically effective amount of a thiazide, or pharmaceutically acceptable salt thereof, and coadministering a therapeutically effective amount of allopurinol, or pharmaceutically acceptable salt thereof, wherein coadministering comprises administering an amount of allopurinol sufficient to reduce lipid-producing effects of thiazide.

### Claim 7 (depends on 6)

The method of claim 6, wherein said allopurinol is administered simultaneously with said thiazide.

### Claim 8 (depends on 6)

The method of claim 6, wherein said allopurinol is administered before said thiazide.

### Claim 9 (depends on 6)

The method of claim 6, wherein said allopurinol is administered after said thiazide.

### Claim 10 (depends on 6)

The method of claim 6, wherein said thiazide is chlorothiazide, benzylhydro-chlorothiazide, cyclopenthiazide, ethiazide, hydrochlorothiazide, hydroflumethiazide, methyclothiazide, penfluthiazide, polythiazide, or trichloromethiazide or a combination thereof.

### Claim 11 (depends on 6)

The method of claim 6, wherein said thiazide is hydrochlorothiazide, or a pharmaceutically acceptable salt thereof.

### Claim 12 (depends on 6)

The method of claim 6, wherein said thiazide, or pharmaceutically acceptable salt thereof and said allopurinol, or pharmaceutically acceptable salt thereof, are administered orally.

### Claim 13 (depends on 6)

The method of claim 6, wherein said thiazide, or pharmaceutically acceptable salt thereof, or allopurinol, or pharmaceutically acceptable salt thereof, are administered orally.

### Claim 14 (depends on 6)

The method of claim 6, wherein said thiazide, or pharmaceutically acceptable salt thereof, or allopurinol, or pharmaceutically acceptable salt thereof, are administered parenterally.

### Claim 15 (depends on 6)

The method of claim 6, wherein said thiazide, or pharmaceutically acceptable salt thereof, and allopurinol, or pharmaceutically acceptable salt thereof, are administered together in a solid dosage form comprising a powder, granule, tablet, pill, or capsule.

### Claim 16 (depends on 1)

A method of treating or preventing hypertension in a patient in need thereof comprising administering a therapeutically effective amount of a composition of claim 1.

### Claim 17

A method of reducing thiazide induced hyperlipidemia in a patient in which a thiazide is being administered comprising coadministering a therapeutically effective amount of allopurinol, or pharmaceutically acceptable salt thereof, wherein said therapeutically effective amount is sufficient to reduce the lipid producing effect of said thiazide.
